Home › Amgen Announces Top-Line Secondary Endpoint Results Of Phase 3...
 

Keywords :   


Amgen Announces Top-Line Secondary Endpoint Results Of Phase 3...

2014-11-05 13:20:10| Biotech - Topix.net

Amgen today announced the top-line secondary endpoint results of overall survival from the Phase 3 TRINOVA-1 trial in women with recurrent platinum-resistant ovarian cancer. The study, which evaluated trebananib plus paclitaxel versus placebo plus paclitaxel, did not demonstrate a statistically significant improvement in overall survival.

Tags: results phase secondary announces

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
14.05Biden hits Chinese electric cars with higher tariffs
14.05University of Sydney Researchers Working on Potential New Use For Landfill Gas
14.05Niyeti Shah Advocates for Better Food Systems
14.05True Corporation has releases 1Q 2024 results
14.05FuboTV releases results for quarter ended March 31, 2024
14.05IDC forecasts slower growth for global telecoms market
14.05Chunghwa Telecom reports results for the first quarter of 2024
14.05Indorama Ventures Reports Improved Performance in 1Q 2024
More »